AEMD logo

Aethlon Medical, Inc. Stock Price

NasdaqCM:AEMD Community·US$3.4m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 6 Fair Values set on narratives written by author

AEMD Share Price Performance

US$2.12
-25.82 (-92.41%)
US$2.12
-25.82 (-92.41%)
Price US$2.12

AEMD Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with moderate risk.

5 Risks
0 Rewards

Aethlon Medical, Inc. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$11.5m

Other Expenses

-US$11.5m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-7.34
0%
0%
0%
View Full Analysis

About AEMD

Founded
1984
Employees
9
CEO
James Frakes
WebsiteView website
www.aethlonmedical.com

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.

Recent AEMD News & Updates

Recent updates

No updates